Papillary thyroid carcinoma (PTC) is the most common type of endocrine cancer, with an
increasing incidence worldwide. The treatment of PTC is currently the subject of clinical …

Simple Summary Thyroid nodules are frequently detected, but the majority of these nodules
are benign. Molecular markers have become useful for diagnosing the minority of thyroid …

Background The thyroid cancer subtype that occurs more frequently is papillary thyroid
carcinoma (PTC). Despite a good surgical outcome, treatment with traditional antitumor …

Background Lateral lymph node metastasis (LLNM) has been considered a risk factor of
recurrence in papillary thyroid cancer (PTC). Preoperative detecting LLNM accurately is …

Background Detection of cancer in patients with thyroid nodules requires sensitive and
specific diagnostic modalities that are accurate and inexpensive. This study aimed to identify …

Abstract Purpose Radioiodine I-131 (RAI) is the therapy of choice for differentiated thyroid
cancer (DTC). Between 5% and 15% of DTC patients become RAI refractory, due to the loss …

Simple Summary PLA2R1 is a promising biological candidate for exploitation in thyroid
cancer. However, the mechanism of action of PLA2R1 in thyroid cancer has not been fully …

Thyroid cancer is a common malignant tumor with rising incidence worldwide. The purpose
of this study was to explore key genes in thyroid cancer. The differentially expressed genes …

Epithelial ovarian cancer (EOC) is the most aggressive and frequent malignancy detected
among women worldwide. The pathophysiology of OC should, therefore be better …

Abstract Papillary Thyroid Carcinoma (PTC) accounts for approximately 85% of patients with
thyroid cancer. Despite its indolent nature, progression to higher stages is expected in a …